In a landmark victory for justice and public health, Rabin Kammerer Johnson (RKJ) and Searcy Denney Scarola Barnhart & ...

The DEA’s potential rescheduling of cannabis to a Schedule III drug could ease restrictions, boosting research and offering ...

The STATES 2.0 Act, a bipartisan bill, would remove marijuana from the Controlled Substances Act, allowing states to regulate ...

National pharmaceutical retailer Walgreens has agreed to pay at least $300 million to settle allegations it illegally fulfilled millions of invalid controlled substance prescriptions for more than ...

A Houston pharmacy, Nnwood Pharmacy, and its owners, Cheryl Brew Greenleaf and Wendell Kirk Greenleaf, are under investigation for allegedly dispensing controlled substances like hydrocodone and ...

Per the terms of the settlement, Walgreens will pay the federal government $300 million to resolve allegations that the company violated both the Controlled Substances Act and the False Claims Act ...

Ricardo Jordan was sentenced to 60 months for selling fentanyl to an undercover officer. The U.S. Attorney’s Office reported ...

President Donald Trump 's pick to run the Drug Enforcement Administration (DEA) is apparently considering a proposal to ...

signaled its intention to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act. This shift acknowledges cannabis’s medical potential and eases some research ...

Outdated federal policies concerning cannabis have impeded research and prevented patients from accessing the full ...